Navigation Links
Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
Date:8/5/2008

RICHMOND, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 4:30 p.m. (ET) on Tuesday, August 12, 2008, at the 28th Canaccord Adams Global Growth Conference in Boston.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Other therapeutic development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic p
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
2. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
3. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
4. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
5. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
7. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
8. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
9. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
10. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
11. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...s a research industry first, allowing veterinary r... safety study data to be managed in one software a...s, NJ (PRWEB) November 9, 2009 -- Xybion Medical S...ma™ VM, an integrated enterprise software so...and care of veterinary research subjects. Pristima...
(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...wswire/ -- EUCODIS Bioscience, a company,developin...es for the,chemical industry announced today that ...Sidus, the leading biopharmaceutical company in La...S Bioscience exclusive access - for the search,of ...llection of,psychrophilic bacteria strains and oth...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...therapy reversed hemophilia in mice , , GAITHERSB... today the publication of a new research article, ...nscripts for Production of Therapeutic Proteins I... study describes a novel RNA therapy technique in ...lbumin gene "hijacks" the albumin, causing it to p...
...LE, Ariz., April 6 MedTrust Online, announced tod...l Research Institute (SCRI) at Scottsdale Healthca...e knowledge discovery and collaboration tools at ...ill enable more access to the latest therapies to ...nt for physicians to find and communicate with eac...
... ACI EUROPE, CANSO, EUROCONTROL an...duce the CO2 emitted by aircraft in Europe by over... Geneva, Switzerland (PRWEB) April 6, 2009 ...d a joint action plan designed to reduce the CO2 e...n tonnes a year., , , , ,The plan, launched at the...
Other Biology Technology:VIRxSYS Publishes New Study on RNA Therapy 2MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care 2Aviation partners to cut 500,000 tonnes of CO2 a year 2
(Date:11/9/2009)...gists have had their hands tied because more than ...ble a protein called p53. As a critical anti-cance...g operations within cells. When cells lose p53, tu.... , These tumors might be tough, but they,re no...g Harbor Laboratory (CSHL). The chink in the tumor...
(Date:11/9/2009)...ngs has inspired a 3.2m, three-year research proje...ds of security, energy and the environment. The Un...mpany QinetiQ have just signed a collaborative con...reaking physical sciences research. , Over the ...versity of Exeter and QinetiQ will work together t...
(Date:11/9/2009)... A nutritionist whose research was instrumental in..., Infants and Children (WIC) food subsidy will rec...tstanding achievement in the field of maternal-fet... professor in the Department of Community Health S...es School of Public Health, will receive the award...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Older Women May Sleep Better Than Men 58638 1Older Women May Sleep Better Than Men 58638 2Heart Pacing Devices Hold Promise for Heart Failure 58636 1Heart Pacing Devices Hold Promise for Heart Failure 58636 2
...N, N.J. Katherine Freed, undergraduate at Stevens...nternational ISPE Undergraduate Poster Contest in ...mpetitor from New Jersey to win this ISPE award. H...d on a project she created with her Senior Design ...gional ISPE Poster Contest was hosted by the Steve...
... release is available in Spanish . , Idiopathic ... with a very severe prognosis; when detected, it i... from it cannot develop with normality pulmonary g...fe. Because of lack of an effective treatment, the...iopathic pulmonary fibrosis affects 13 out of 100,...
...svirus May Play Role in Central Nervous System Dis...esting a herpesvirus may be responsible for some c...from the New York State Department of Public Healt...n the December 2007 issue of the Journal of Clinic... one of the most prevalent in humans. There are t...
Other Biology News:Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3
QIAshredder (50) from QIAGEN
...I 1640 medium with 2 mM L-glutamine and harvested ...antigens in their native forms, cells were fixed i...-well (5 mm) adhesive coated slide, with each well... attachment and to minimize background staining. ...
...PMI 1640 with 2 mM L-glutamine and harvested at th...ens in their native forms, cells were fixed in ace... (5 mm) adhesive coated slide, with each wells sur...chment and to minimize background staining. Each ...
Mouse Anti-Human XPMC2H Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: